Ranolazine 00615-8611-39
- Manufacturer
- Ncs Healthcare Of Ky, Llc Dba Vangard Labs
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 10, 2019
- Listing Expires
- December 31, 2027
- Application
- ANDA210188
Need to source Ranolazine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ranolazine | 500 mg/1 |
Drug Class
Anti-anginal [EPC]Anti-anginal [EPC]Cytochrome P450 2D6 Inhibitors [MoA]
Selected Package
00615-8611-39Selected30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8611-39)